Who are the top shareholders of the Natraj Proteins?

The top shareholders of Natraj Proteins include promoter Sharad Kumar Jain with 6.38% and public shareholder Sangeetha S with 5.75%. Individual investors hold 50.62% of shares, with no pledged promoter holdings and minimal institutional involvement.

The top shareholders of Natraj Proteins include Sharad Kumar Jain, who is the promoter with the highest holding at 6.38%. The highest public shareholder is Sangeetha S, holding 5.75%. Additionally, individual investors collectively hold 50.62% of the company's shares. There are no pledged promoter holdings, and the company has minimal institutional involvement, with only one mutual fund scheme holding 1.9% and no foreign institutional investors.

Who are in the management team of Natraj Proteins?

As of March 2022, the management team of Natraj Proteins includes Kailash Chand Sharma (Chairman & Managing Director), Sharad Kumar Jain (Whole-time Director), and several independent directors, along with Pooja Agrawal as Company Secretary. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Natraj Proteins includes the following individuals:<BR><BR>1. Kailash Chand Sharma - Chairman & Managing Director (Remuneration: Rs. 10.8 lacs)<BR>2. Sharad Kumar Jain - Whole-time Director (Remuneration: Rs. 6.6 lacs)<BR>3. Umesh Trivedi - Independent Director (Remuneration: Rs. 25.0 k)<BR>4. Pradeep Agrawal - Independent Director (Remuneration: Rs. 20.0 k)<BR>5. Namita Sharma - Director (Remuneration: Rs. 25.0 k)<BR>6. Rajendra Singh Tomar - Independent Director (Remuneration: Rs. 20.0 k)<BR>7. Pooja Agrawal - Company Secretary & Compliance Officer (Remuneration: Rs. 3.6 lacs)<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

What does Natraj Proteins do?

Natraj Proteins Ltd is a micro-cap company in the edible oil industry, specializing in crude oil, refined oil, and de-oiled cake production. As of March 2025, it reported net sales of 23 Cr and a net profit of 1 Cr, with a market cap of Rs 15 Cr.

Overview:<BR>Natraj Proteins Ltd operates in the edible oil industry as a micro-cap company, specializing in the manufacture of crude oil, edible grade refined oil, and de-oiled cake.<BR><BR>History:<BR>Incorporated in November 1990, Natraj Proteins Ltd has maintained its focus on solvent extraction for oil production. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 23 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 1 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 15 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 21 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.15 <BR>Return on Equity: -4.33% <BR>Price-to-Book: 0.45<BR><BR>Contact Details:<BR>Address: Nagpur Kalan, Ordinance Factory Road Itarsi Madhya Pradesh : 461111 <BR>Tel: 91-07572-262636 <BR>Email: natrajproteins@rediffmail.com <BR>Website: http://www.natralproteins.com

Has Natraj Proteins declared dividend?

No Dividend History Available

Who are the peers of the Natraj Proteins?

Natraj Proteins' peers include Marico, Patanjali Foods, AWL Agri Business, Gokul Agro, Sundrop Brands, CIAN Agro, Kriti Nutrients, Ashiana Agro Ind, and Signature Green. In terms of management risk, growth, and capital structure, Natraj Proteins ranks below average compared to its peers, with a 1-year return of -12.26%.

Peers: The peers of Natraj Proteins are Marico, Patanjali Foods, AWL Agri Busine., Gokul Agro, Sundrop Brands, CIAN Agro, Kriti Nutrients, Ashiana Agro Ind, and Signature Green.<BR><BR>Quality Snapshot: Excellent management risk is observed at Marico, while Average management risk is found at Patanjali Foods, Gokul Agro, and Kriti Nutrients, and the rest. Below Average management risk is noted for AWL Agri Busine., CIAN Agro, and Sundrop Brands, and the rest. Growth is Excellent for Patanjali Foods, Gokul Agro, and CIAN Agro, while Average growth is seen at AWL Agri Busine., and the rest. Below Average growth is reported for Marico, Sundrop Brands, Kriti Nutrients, and Natraj Proteins. Capital Structure is Excellent at Marico and Kriti Nutrients, Good at Patanjali Foods, AWL Agri Busine., Gokul Agro, and Sundrop Brands, while Below Average is noted for CIAN Agro and Natraj Proteins.<BR><BR>Return Snapshot: CIAN Agro has the highest 1-year return at 1035.92%, while AWL Agri Busine. has the lowest at -27.28%. Natraj Proteins' 1-year return of -12.26% is better than AWL Agri Busine. but worse than all other peers. Additionally, the six-month return is negative for AWL Agri Busine., Gokul Agro, and Ashiana Agro Ind.

What is the technical trend for Natraj Proteins?

As of May 12, 2025, Natraj Proteins shows a mildly bearish trend with mixed signals: the weekly MACD is mildly bullish, the monthly MACD is bearish, and while the RSI is bullish on the monthly chart, Bollinger Bands and moving averages indicate bearishness across both daily and monthly charts.

As of 12 May 2025, the technical trend for Natraj Proteins has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish, suggesting mixed signals across time frames. The RSI shows no signal on the weekly chart but is bullish on the monthly, indicating potential strength in longer-term momentum. However, Bollinger Bands and moving averages are bearish on both daily and monthly charts, reinforcing the overall bearish sentiment. The KST is mildly bullish weekly but bearish monthly, further contributing to the mixed outlook. Overall, the current stance is mildly bearish, with key indicators showing divergence between short-term and long-term trends.

How big is Natraj Proteins?

As of 24th July, Natraj Proteins Ltd has a market capitalization of 16.00 Cr and reported Net Sales of 117.79 Cr, with a Net Profit loss of 1.46 Cr over the latest four quarters. The balance sheet for March 2024 shows Shareholder's Funds of 33.71 Cr and Total Assets of 77.83 Cr.

As of 24th July, Natraj Proteins Ltd has a market capitalization of 16.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Natraj Proteins reported Net Sales of 117.79 Cr. However, the company experienced a Net Profit loss of 1.46 Cr during the same period.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 33.71 Cr and Total Assets amounting to 77.83 Cr.

When is the next results date for Natraj Proteins?

The next results date for Natraj Proteins is 13 August 2025.

The next results date for Natraj Proteins is scheduled for 13 August 2025.

Are Natraj Proteins latest results good or bad?

Natraj Proteins' latest results are disappointing, with a Profit After Tax of Rs -1.21 crore and a 9.8% decline in net sales to Rs 26.56 crore, leading analysts to recommend a 'Strong Sell' due to ongoing profitability challenges.

Natraj Proteins' latest financial results are disappointing. For the quarter ending June 2025, the company reported a Profit After Tax (PAT) of Rs -1.21 crore, which marks a significant decline of 231.5% compared to the average PAT of Rs -0.37 crore over the previous four quarters. This indicates ongoing challenges in achieving profitability.<BR><BR>Additionally, net sales decreased to Rs 26.56 crore, reflecting a 9.8% drop from the average net sales of Rs 29.45 crore in the preceding quarters. While there was a slight improvement in net sales growth compared to the previous quarter, the overall trend remains negative, highlighting the company's struggles in the current market.<BR><BR>Due to these financial setbacks, analysts have issued a 'Strong Sell' recommendation for Natraj Proteins, emphasizing the deteriorating performance of the company in recent months. Overall, the results suggest that Natraj Proteins is facing significant difficulties.

How has been the historical performance of Natraj Proteins?

Natraj Proteins has experienced significant fluctuations in financial performance, with declining net sales and operating income, but improved cash flow from operations. Despite a positive operating profit in Mar'25, the company continues to face challenges with negative profits before and after tax.

Answer:<BR>The historical performance of Natraj Proteins shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Natraj Proteins experienced a decline in net sales from 193.73 Cr in Mar'24 to 117.78 Cr in Mar'25, following a trend of decreasing sales since Mar'23 when it was 143.60 Cr. The total operating income mirrored this decline, dropping to 117.78 Cr in Mar'25 from 193.73 Cr in Mar'24. Raw material costs also decreased significantly, falling from 150.82 Cr in Mar'24 to 95.70 Cr in Mar'25. Despite this reduction in costs, the operating profit (PBDIT) turned positive at 1.61 Cr in Mar'25 after being negative in Mar'24. However, the company reported a profit before tax of -1.18 Cr in Mar'25, indicating ongoing challenges. The profit after tax also remained negative at -1.46 Cr. The total liabilities decreased from 77.83 Cr in Mar'24 to 58.63 Cr in Mar'25, while total assets also fell from 77.83 Cr to 58.63 Cr in the same period. Cash flow from operating activities showed improvement, reaching 21.00 Cr in Mar'25 compared to -5.00 Cr in Mar'24, but the net cash inflow/outflow remained at 0.00 Cr in Mar'25. Overall, Natraj Proteins has faced significant challenges in profitability and sales, while managing to improve cash flow from operations.

Should I buy, sell or hold Natraj Proteins?

Is Natraj Proteins overvalued or undervalued?

As of November 17, 2025, Natraj Proteins is considered undervalued with a valuation grade shift to attractive, featuring a PE ratio of -9.07 and an EV to EBITDA of 34.42, significantly lower than peers like Gokul Agro and Guj. Ambuja Exp, despite a year-to-date return of -14.80% compared to the Sensex's 8.72%, indicating potential for recovery and growth.

As of 17 November 2025, the valuation grade for Natraj Proteins has moved from expensive to attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of -9.07, an EV to EBITDA of 34.42, and a Price to Book Value of 0.49, which highlight its low valuation compared to earnings and assets.<BR><BR>In comparison to peers, Gokul Agro has a PE ratio of 20.15 and an EV to EBITDA of 10.23, while Guj. Ambuja Exp shows a PE of 22.97 and an EV to EBITDA of 11.75, both of which are considerably higher than Natraj Proteins. This suggests that Natraj is trading at a discount relative to its peers in the edible oil industry. Despite recent underperformance against the Sensex, with a year-to-date return of -14.80% compared to the Sensex's 8.72%, the attractive valuation suggests potential for recovery and growth.

Which are the latest news on Natraj Proteins?

Why is Natraj Proteins falling/rising?

As of 04-Dec, Natraj Proteins Ltd's stock price is rising to 38.12, reflecting a 2.56% increase after a trend reversal. However, it has a year-to-date decline of 14.53% and shows weaker long-term performance despite today's gains.

As of 04-Dec, Natraj Proteins Ltd's stock price is rising, currently at 38.12, reflecting a change of 0.95 or 2.56% increase. This upward movement comes after a trend reversal, as the stock has gained after four consecutive days of decline. Additionally, it has outperformed its sector by 6.23%. Despite this positive movement today, the stock has shown a negative performance over longer periods, with a year-to-date decline of 14.53% and a 3-year decline of 39.87%. <BR><BR>The stock's current price is higher than its 5-day moving averages but remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages, indicating a short-term recovery while still being under pressure in the longer term. Furthermore, there has been a significant drop in investor participation, with delivery volume on 03 Dec falling by 90.96% compared to the 5-day average, which may suggest caution among investors despite today's price increase. Overall, while the stock is experiencing a rise today, it is important to consider the broader context of its recent performance and market conditions.